Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The parasite heme detoxification pathway is a critical metabolic process utilized by Plasmodium species during their intraerythrocytic life cycle stage (Francis et al., 1997). As the parasite digests host hemoglobin to acquire essential amino acids, it releases large quantities of free heme (ferriprotoporphyrin IX), which is highly toxic due to its ability to generate reactive oxygen species and disrupt cellular membranes (Egan et al., 2002). To mitigate this toxicity, the parasite converts free heme into an insoluble, chemically inert crystalline polymer known as hemozoin, or malaria pigment (Pagola et al., 2000). This biocrystallization process is primarily mediated by the Heme Detoxification Protein (HDP) and occurs within the parasite's acidic digestive vacuole (Jani et al., 2008). Many classic antimalarial drugs, particularly the quinoline class such as chloroquine and quinine, exert their therapeutic effect by binding to heme monomers or the growing crystal surface, thereby inhibiting polymerization (Sullivan et al., 1996). The resulting accumulation of toxic free heme leads to oxidative damage and the eventual death of the parasite, making this pathway one of the most successful targets in the history of antimalarial chemotherapy.
Inhibition of heme polymerization into hemozoin crystals, resulting in the accumulation of toxic free ferriprotoporphyrin IX (FP) within the parasite (Sullivan et al., 1996). Artemisinins may also interact with heme to generate toxic free radicals (Cui & Su, 2009).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parasite heme detoxification pathway.